- Home
- Applications
- us virgislands
- diabetes type
Refine by
Diabetes Type Product Applications Available In Us Virgin Islands
16 applications found
Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Of the three types of diabetes (Type 1, Type 2, and gestational), Type 2 accounts for over 90% of the total cases of diabetes. The increased prevalence of diabetes and obesity (a risk factor for Type 2 diabetes) has increased dramatically from 1994 to 2014 and is expected to grow. There are 86 million Americans with pre-diabetes (1/3rd of the ...
ByAlertgy based in Melbourne, FLORIDA (USA)
Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. https://www.bocsci.com/saxagliptin-impurity-15-cas-1496712-39-0-item-479445.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
1 in 10 American have diabetes. Over 88 million Americans are pre-diabetic. Tesis Biosciences is working with physicians and research organizations to reverse this epidemic by helping to identify people with prediabetes, predict likelihood of diabetes to help prevent type 2 diabetes, identify and prevent diabetes complications, and improve the health of all people with diabetes. ...
ByTesis Biosciences based in Scottsdale, ARIZONA (USA)
We are advancing a novel, oral approach to type 2 diabetes and obesity, two conditions of epidemic proportions in need of improved treatment options. ...
ByKallyope Inc. based in New York City, NEW YORK (USA)
When you have type 2 diabetes, your body isn’t able to properly use insulin to bring glucose into your cells. ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)
We are revolutionizing the way you will manage your Type 2 diabetes, applying leading edge sensor and materials technologies to detect blood sugar levels and present them to you through Alertgy ...
ByAlertgy based in Melbourne, FLORIDA (USA)
Type 1 diabetes is a common chronic disease, affecting millions of people throughout the world, in which the immune system attacks the body’s own pancreatic cells, stopping the production of insulin. Though it was previously considered a childhood disease, type 1 diabetes is known to affect people at every age, and it has no ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
Once seen only among adults, diseases such as Type 2 diabetes are becoming more common in paediatrics and adolescent population due to diet and sedentary lifestyle. ...
ByTensiomed based in Budapest, HUNGARY
Despite advances in treatment over the past 50 years, metabolic diseases in general, and type 2 diabetes (T2D) in particular, continue to be a principal and rapidly growing driver of morbidity and mortality in the 21st century. ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)
Diabetic macular edema is a complication of diabetes caused by fluid accumulation in the macula, or central portion of the eye. The macula is filled with cones, the nerve cells that are responsible for sensing light. When the macula begins to fill with fluid, the ability of those cells to sense light is impaired, causing blurred vision that can be severe. Vision loss from DME can progress over a period of months and make it impossible to focus ...
ByLutronic Vision based in Billerica, MASSACHUSETTS (USA)
GI Dynamics has taken all necessary COVID-19 precautions to ensure patient safety, which remains top priority. Patient screening for the STEP-1 pivotal trial of EndoBarrier has reopened at select sites and enrollment will be conducted according to site requirements and CDC/FDA ...
ByGI Dynamics, Inc. based in Boston, MASSACHUSETTS (USA)
The increase or decrease of a natural immune response to obtain a therapeutic result is the basis of immunotherapy. It holds great promise for the treatment of autoimmune diseases, cancer, and the prevention of transplant ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Diabetes occurs when glucose (sugar) builds up in the blood. This buildup causes an inability of the body to use the glucose for energy. This inability happens when the insulin does not function correctly. Many people believe that diabetes is a “sugar problem” but it is actually an “insulin ...
ByProdigy Diabetes Care, LLC based in Charlotte, NORTH CAROLINA (USA)
Aortic pulse wave velocity (PWVao) is a powerful independent predictor of mortality in both Diabetes and glucose intolerance test population samples. In displacing systolic blood pressure as a prognostic factor, aortic pulse wave velocity represents a useful integrated index of vascular status and hence cardiovascular diseases. Considering the Diabetes as a vascular disease, the measurement of the aortic stiffness plays an extremely important role in evaluation of the special cardiovascular risk ...
ByTensiomed based in Budapest, HUNGARY